CBDL OTC
CBD Life Sciences Inc.
1W: +0.0%
1M: -50.0%
3M: -66.7%
YTD: -50.0%
1Y: -83.3%
3Y: -100.0%
5Y: -100.0%
$0.00
-0.00 (-50.00%)
Weekly Expected Move ±70.3%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$139K
+76.1% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$139K
+76.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$325K
+7959.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$5M | -$860K | -$79K | -$757K | -$49K |
| Depreciation & Amort. | $0 | $54K | $56K | $56K | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$19K | -$151K | $754 | $119K | -$90K |
| Other Non-Cash Items | $0 | $153K | $6K | $0 | $0 |
| Operating Cash Flow | -$5M | -$804K | -$17K | -$583K | -$139K |
| — Investing Activities — | |||||
| Capital Expenditures | -$162K | -$69K | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $47K |
| Investing Cash Flow | -$162K | -$69K | $0 | $0 | $47K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$153K | $19K | $0 | $0 |
| Financing Cash Flow | $7M | -$153K | $19K | $587K | $144K |
| Net Change in Cash | $1M | -$1M | $2K | $4K | $325K |
| Cash End of Period | $1M | $558 | $3K | $7K | $332K |
| Free Cash Flow | -$5M | -$1M | $2K | -$583K | -$139K |